The University of the Incarnate Word’s Feik School of Pharmacy (FSOP) is proud to announce that Dr. Helmut Gottlieb has received the MBRS-SCORE grant from the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH). The Minority Biomedical Research Support (MBRS) – Support of Continuous Research Excellence (SCORE) program’s $360,000 grant will fund a project entitled Central Kappa Opioid Neural Regulation of Cardiovascular and Renal Function which is expected to run approximately 3 years.
The goal of these studies is to identify the central nervous system sites and neuronal pathways by which central kappa opioid systems modulate renal function in normal systems and in systems which have cirrhosis of the liver. The study, led by Gottlieb, will provide basic knowledge of how different systems interact and modulate water and sodium balance under normal and pathologic conditions. Ultimately, opioid compounds could be developed and used to treat fluid overload where hyponatremia is also present which could be potentially life-saving for many. Hyponatremia is a metabolic condition in which there is not enough sodium (salt) in the body fluids outside the cells.
“As dean of the UIW Feik School of Pharmacy, I am impressed with the caliber of grant writing and research we are able to produce in such a short period of existence. I expect others will follow Dr. Gottlieb and secure more major funding from NIH,” said Dr. Arcelia M. Johnson-Fannin.
Gottlieb an assistant professor of pharmaceutical sciences at UIW’s FSOP has a bachelor’s degree from Texas A&M-Kingsville and a Ph.D. in Pharmacology from the Louisiana State University Health Sciences Center. Gottlieb is a member of the American Physiological Society (APS), American Society for Pharmacology and Experimental Therapeutics, and American Association of Colleges of Pharmacy (AACP). In addition to presenting his work in national and international meetings, he has published his work in journals such as the Journal of Pharmacology and Experimental Therapeutics, American Journal of Physiology, Journal of Neuroendocrinology, and Experimental Neurology.
For more information, contact Margaret Garcia, associate director of public relations at 210-829-6001 or at firstname.lastname@example.org.